...
首页> 外文期刊>The Professional Medical Journal >EFFECTIVENESS OF TREATING PREVIOUSLY UNTREATED PATIENTS WITH BOTH A GLUTEN FREE DIET AND BISPHOSPHONATE, GLUTEN FREE DIET ALONE
【24h】

EFFECTIVENESS OF TREATING PREVIOUSLY UNTREATED PATIENTS WITH BOTH A GLUTEN FREE DIET AND BISPHOSPHONATE, GLUTEN FREE DIET ALONE

机译:不含麸质饮食和双磷酸盐,单独服用麸质饮食治疗未曾治疗过的患者的疗效

获取原文

摘要

Objective: To evaluate effectiveness of treating previously untreated patients with celiac disease with both a gluten free diet and bisphosphonate in order to significantly increase their BMD's to a greater extent than a gluten free diet alone. Patients and methods: The study was conducted in National Institute of Child Health (NICH) Karachi to evaluate the effectiveness of treating previously untreated patients with cel iac disease with a gluten free diet and bisphosphonate in terms of increase in bone mineral density in comparison to a gluten free diet alone over a period of three months (January 2013 – March 2013). The study includes 30 children patients below fifteen years of age either sex. All study subjects were untreated celiac patients diagnosed by clinical presentation, small bowel histology and serologic testing. On day dexa scan was done. Fifteen patients kept on Gluten Free Diet (GFD) and remaining 15 patients kept GFD plus tablet of bisphosphonate. After three months dexa scan was repeated. The patients with other disease of bone or mineral metabolism, as well as subjects taking systemic glucocorticoids or high doses of thyroid hormones, were excluded. Results: A total of 30 patients with celiac disease were included in this study. Out of 30 patients 18 (60%) were female and 12 (40%) male (M: F = 1:1.5). Thirty patients were divided in two equal groups (15 patients in each group). In group-I we gave gluten free diet and in group-II we gave gluten free diet and one tablet of bisphosphonate. Mean± SD of Bone Mineral Density (BMD) in group-I was 0.402± 0.081 gm/cm2 (range=0.234 – 0.503 gm/cm2), and in group-II was 0.543± 0.098 gm/cm2 (range= 0.402 – 0.743 gm/cm2), mean difference of bone mineral density was significant between two groups (P-value=0.0002). Conclusions: At three months DEXA scan showed a significant rise in BMD in group-II as compared to group-I
机译:目的:评估无麸质饮食和双磷酸盐治疗既往未治疗的乳糜泻患者的有效性,以使他们的BMD显着提高到比无麸质饮食单独更大的程度。患者和方法:该研究是在卡拉奇国家儿童健康研究所(NICH)进行的,以评估无骨质饮食和双膦酸盐治疗以前未经治疗的cel acac病患者与骨矿物质密度增加相比的有效性。在三个月内(2013年1月至2013年3月),仅使用无麸质饮食。该研究包括30名年龄在15岁以下的男女儿童。所有研究对象均为未经临床治疗,临床表现,小肠组织学和血清学检查确诊的乳糜泻患者。当天进行了dexa扫描。 15例患者保持无麸质饮食(GFD),其余15例患者保持GFD加双膦酸盐片剂。三个月后,重复进行dexa扫描。患有其他骨或矿物质代谢疾病的患者以及服用全身性糖皮质激素或高剂量甲状腺激素的受试者被排除在外。结果:本研究共纳入30例腹腔疾病患者。在30位患者中,有18位(60%)是女性,而12位(40%)是男性(M:F = 1:1.5)。 30例患者分为两组,每组15例。在第一组中,我们给予无麸质饮食,在第二组中,我们给予无麸质饮食和一粒双膦酸盐。第一组的骨矿物质密度(BMD)的平均值±SD为0.402±0.081 gm / cm2(范围= 0.234 – 0.503 gm / cm2),第二组的骨密度为0.543±0.098 gm / cm2(范围= 0.402 – 0.743) (gm / cm2),两组之间的骨矿物质密度平均差异显着(P值= 0.0002)。结论:在三个月的时间里,DEXA扫描显示,与I组相比,II组的BMD显着升高

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号